AlzeCure Pharma AB (publ)
SSE:ALZCUR.ST
Overview | Financials
Company Name | AlzeCure Pharma AB (publ) |
Symbol | ALZCUR.ST |
Currency | SEK |
Price | 2.49 |
Market Cap | 154,596,630 |
Dividend Yield | 0% |
52-week-range | 2.03 - 6.54 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Martin Jönsson |
Website | https://www.alzecurepharma.se |
An error occurred while fetching data.
About AlzeCure Pharma AB (publ)
AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is developing drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its pipeline drug candidates include ACD856, which is in phase I
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD